Guest guest Posted February 14, 2007 Report Share Posted February 14, 2007 zoe, regarding yr comments: The Ghent/Eskin studies on the breast (one of the best series of research studies and the ones that Abraham often quotes) did not use 12 mg of molecular iodine, and they did not use Iodoral, and they did not find that Lugol's was the most effective form of iodine. do you know the name of the iodine used in this study? sandraZoe & <ZOEA@...> wrote: Amy, I think the main point is that people -- including the iodine experts -- differ greatly on what level of iodine they think is health promoting. It is good for us all to remember that this is a very young field and Abraham et al is just one point of view. A valuable point of view, but not the only one. There is a great deal of controversy in the research literature about how much iodine the Japanese actually get. When I first read the Abraham articles and the debate, I looked through the research trying to decide for myself how much iodine the Japanese were getting. I eventually gave up. Everybody differed on how to interpret the data and what data were relevant. And the Japanese on the coasts got a lot more than the Japanese that lived inland or in various provinces. If I recall correctly, I think the consensus seemed to be close to 3 mg/day of iodine in Japan in common areas near the coasts. By this point in our personal health journeys, we have all learned that the authorities do not always know best. It is very important for us to think for ourselves. That's why this group is so important. We can get exposed to different points of view and, thereby, start to question what people tell us and what we ourselves believe to be true. Abraham et al have provided an incredible service by challenging the conventional belief in the RDA of 150 mcg and the assumption that iodine over 1 mg is toxic. It is invaluable what he has done. Still, we would be in error to assume that everything he says is absolute truth. We do not yet know the ideal amount of iodine for different people. We know that molecular iodine (I2) is critical for the breast, but we don't know how much molecular iodine is really in Iodoral or what it turns into once we swallow it. We have no idea how much the breast needs in general, or for any particular woman. We are just beginning to understand how the molecular iodine gets into the breast or is created from the iodide inside the cells. The Ghent/Eskin studies on the breast (one of the best series of research studies and the ones that Abraham often quotes) did not use 12 mg of molecular iodine, and they did not use Iodoral, and they did not find that Lugol's was the most effective form of iodine. We need to think for ourselves, look at the evidence, and be willing to challenge any idea. Exposing ourselves to differing points of view helps us in that process. One of the hardest parts of that journey is learning to live with not knowing. Zoe ----- Original Message ----- From: Amy Bridenball iodine Sent: Tuesday, February 13, 2007 7:46 PM Subject: Re: iodine RDA and dosing The assertions made by some for 12-50 mg/d are just that: assertions. There is no data that suggests real harm, but also no real scientific basis for it. Hi Zoe,So this person doesn't feel Dr Abrahams research was "scientific"? Because if memory serves, Abraham's amount stems from research on how much Japanese women (following a traditional Japanese diet) are getting in their diets. Therefore, what 's good for them, should be good for us. It makes perfectly good sense to me, but I am no doctor. Your friend theoretically, not wanting to give his wife higher than 3 mg/d's would still be way less than what Japanese women are safely consuming everyday of their lives. And we know their rates for thyroid and breast cancer issues. So, I find his comment a bit perplexing. I don't know I am new to all of this, so maybe you can shed some light, or someone else can.Take Care all!Amy Expecting? Get great news right away with email Auto-Check.Try the Beta. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 14, 2007 Report Share Posted February 14, 2007 , Ghent/Eskin used their own formulation of molecular iodine. It was not a named product and is not available for sale because it quickly changes into something other than molecular iodine after it is created. Based on the Ghent/Eskin studies, Symbollon has developed a process for creating molecular iodine that will not degrade. Their product is called IoGen and it is presently in Phase III experimental trials. It is not yet for sale, and won't be until the Phase III trials are over and IoGen is approved by the FDA. As far as I know, the Phase III trials are still in process and are enrolling patients. It is a well-designed study and would be interesting to participate in if you are eligible. That is the only way to get IoGen at this time. Symbollon developed an interesting process for creating molecular iodine by putting together two different ingredients in a pill that, once you swallow it and it is in the acid pH of the stomach, turns into molecular iodine in your stomach. The pill is called IoGen -- because it Generates (molecular) Iodine. In some earlier emails, there was a discussion about how to create your own molecular iodine using iodine crystals. If you are seriously interested, you might want to search the archives of the group for this information. Here are a few links to information on IoGen: IoGen - Breast Pain Clinical Research Trial "Symbollon is enrolling patients in a national multi-center, placebo-controlled, double-blinded, randomized Phase III clinical trial for the treatment of moderate or severe breast pain associated with fibrocystic breast disease. The trial drug, IoGen, may help relieve breast pain. The study has been registered with FDA under the Protocol Registration System at ClinicalTrials.gov." Symbollon provides update on IoGen Phase III Pain Study Symbollon August 9, 2006 "It anticipates closing the enrollment of its IoGen™ Phase III pivotal pain study by yearend. The ongoing IoGen study has over 25 active sites across the United States. Symbollon is planning to conduct a comprehensive advertising campaign during the remainder of 2006 to assist these sites in recruiting subjects for the study by yearend." Research calls for use of molecular iodine to treat breast cancer Symbollon October 31, 2006 "Symbollon Pharmaceuticals, Inc. (OTCBB: SYMBA) today provided a review of recent independent scientific publications focused on the possible use of molecular iodine, the active agent in Symbollon’s drug, IoGen™, to treat breast cancer. The results of such research identify molecular iodine as a possible treatment for breast cancer. This research recommends the initiation of human clinical trials testing molecular iodine as an adjuvant therapy for breast cancer. " http://iodine4health.com/body/breast/kessler_breast.htm Zoe ----- Original Message ----- From: sandra zenishek zoe, regarding yr comments: The Ghent/Eskin studies on the breast (one of the best series of research studies and the ones that Abraham often quotes) did not use 12 mg of molecular iodine, and they did not use Iodoral, and they did not find that Lugol's was the most effective form of iodine. do you know the name of the iodine used in this study? sandra Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 14, 2007 Report Share Posted February 14, 2007 zoe this is a very interesting but I will try to keep an eye on its progress, thank you, sandra Zoe & <ZOEA@...> wrote: , Ghent/Eskin used their own formulation of molecular iodine. It was not a named product and is not available for sale because it quickly changes into something other than molecular iodine after it is created. Based on the Ghent/Eskin studies, Symbollon has developed a process for creating molecular iodine that will not degrade. Their product is called IoGen and it is presently in Phase III experimental trials. It is not yet for sale, and won't be until the Phase III trials are over and IoGen is approved by the FDA. As far as I know, the Phase III trials are still in process and are enrolling patients. It is a well-designed study and would be interesting to participate in if you are eligible. That is the only way to get IoGen at this time. Symbollon developed an interesting process for creating molecular iodine by putting together two different ingredients in a pill that, once you swallow it and it is in the acid pH of the stomach, turns into molecular iodine in your stomach. The pill is called IoGen -- because it Generates (molecular) Iodine. In some earlier emails, there was a discussion about how to create your own molecular iodine using iodine crystals. If you are seriously interested, you might want to search the archives of the group for this information. Here are a few links to information on IoGen: IoGen - Breast Pain Clinical Research Trial "Symbollon is enrolling patients in a national multi-center, placebo-controlled, double-blinded, randomized Phase III clinical trial for the treatment of moderate or severe breast pain associated with fibrocystic breast disease. The trial drug, IoGen, may help relieve breast pain. The study has been registered with FDA under the Protocol Registration System at ClinicalTrials.gov." Symbollon provides update on IoGen Phase III Pain Study Symbollon August 9, 2006 "It anticipates closing the enrollment of its IoGen™ Phase III pivotal pain study by yearend. The ongoing IoGen study has over 25 active sites across the United States. Symbollon is planning to conduct a comprehensive advertising campaign during the remainder of 2006 to assist these sites in recruiting subjects for the study by yearend." Research calls for use of molecular iodine to treat breast cancer Symbollon October 31, 2006 "Symbollon Pharmaceuticals, Inc. (OTCBB: SYMBA) today provided a review of recent independent scientific publications focused on the possible use of molecular iodine, the active agent in Symbollon’s drug, IoGen™, to treat breast cancer. The results of such research identify molecular iodine as a possible treatment for breast cancer. This research recommends the initiation of human clinical trials testing molecular iodine as an adjuvant therapy for breast cancer. " http://iodine4health.com/body/breast/kessler_breast.htm Zoe ----- Original Message ----- From: sandra zenishek zoe, regarding yr comments: The Ghent/Eskin studies on the breast (one of the best series of research studies and the ones that Abraham often quotes) did not use 12 mg of molecular iodine, and they did not use Iodoral, and they did not find that Lugol's was the most effective form of iodine. do you know the name of the iodine used in this study? sandra Don't get soaked. Take a quick peak at the forecast with the Search weather shortcut. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.